Alnylam Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 5.43, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Alnylam Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 67 days, compared to 68 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 348 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2532, from overall ranking in the first quarter 2026 at 2861.

What is Receivable Turnover Ratio?
What is Alnylam Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALNY Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	60.95 %	111.46 %	91.85 %	172.65 %	83.25 %
Y / Y Revenue Change	66.86 %	96.43 %	84.95 %	149.35 %	17.26 %
Receivable Turnover Ratio (TTM)	5.43	5.37	5.45	5.45	5.65
ALNY's Total Ranking	# 2532	# 2861	# 2554	# 2497	# 2252
Accounts Receivable average collection period days	67	68	67	67	65
Seq. Receivable Change	3.26 %	13.68 %	-19.4 %	70.12 %	35.66 %
Seq. Revenue Change	10.6 %	6.39 %	-12.17 %	61.44 %	30.21 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 103
Healthcare Sector	# 349
Overall Market	# 2532

Receivable Turnover Ratio Statistics
High	Average	Low
103.56	13.27	3.23
(Sep 30 2013)		(Mar 31 2018)

ALNY Company Profile • Back to ALNY Efficiency Comparisons • Compare ALNY Receivables Turnover Ratio to its Competitors

Financial Statements
Alnylam Pharmaceuticals Inc 's Accounts Receivable	$ 913 Millions	Visit ALNY's Balance sheet
Alnylam Pharmaceuticals Inc 's Sales TTM	$ 4,804 Millions	Visit ALNY's Income Statement
Sources of ALNY's Revenues		Visit ALNY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALNY's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALNY's Growth Rates	ALNY's Roa	ALNY's Inventory Turnover Ratio	ALNY's Dividend Comparisons
ALNY's Profitability Ratios	ALNY's Roi	ALNY's Asset Turnover Ratio	ALNY's Dividend Growth
ALNY's Valuation Ratios	ALNY's Roe	ALNY's Financial Strength Ratios	ALNY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
China Pharma Holdings Inc	14.46	$ 3.914 Millions	$ 0.271 Millions
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Talkspace Inc	14.09	$ 246.631 Millions	$ 17.506 Millions
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Amneal Pharmaceuticals Inc	13.83	$ 3,117.474 Millions	$ 225.492 Millions
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Skinhealth Systems Inc	13.04	$ 289.224 Millions	$ 22.179 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Teladoc Health Inc	11.74	$ 2,489.480 Millions	$ 212.023 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Innoviva Inc	11.22	$ 420.630 Millions	$ 37.491 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Caredx Inc	10.81	$ 458.089 Millions	$ 42.359 Millions

Date modified: 2026-09-14T03:47:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.